Diameter Capital Partners LP Humacyte, Inc. Transaction History

Diameter Capital Partners LP

  • $984 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$4.65 - $7.4 $1.4 Million - $2.22 Million
-300,338 Closed
0 $0
Q4 2021

Feb 15, 2022
SELL
$7.25 - $11.6 $4.74 Million - $7.58 Million
-653,800 Reduced 68.52%
300,338 $2.18 Million
Q3 2021

Nov 15, 2021
BUY
$9.21 - $16.99 $8.79 Million - $16.2 Million
954,138 New
954,138 $11.1 Million

Others Institutions Holding HUMA

# of Institutions
155
Shares Held
35.4M
Call Options Held
279K
Put Options Held
607K
View Full List

About Humacyte, Inc.

HUMA Quotes by TradingView
  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $472M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Diameter Capital Partners LP Portfolio

Follow Diameter Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diameter Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Diameter Capital Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email